Next Event in Series
Accelerate Licensing & Co-Development Across Neuroscience & CNS Drug Delivery
27-28 April, 2027 | Boston, MA
Demonstrate Differentiation, Understand Pharma’s Strategy, & More Efficiently Secure Deal Conversations
There is no other meeting like the Oncology & Immunology Innovation Partnering & Licensing Summit. This was the only conference specifically built for pharma to efficiently meet, provide feedback on, and compare licensing and co-development opportunities with biotech leaders in a mutually beneficial forum.
Ensuring relevance, favorable pharma-to-biotech ratios, and synergy across attendee interests, this high-impact forum was built from past TPD, ADC, Autoimmunity, and TCE Partnering events.
Built for Depth, Not Dilution:
Why Attendees Prioritized this Differentiated Business Development Initiative?
- Large Pharma: Easily compared pipelines and enabling technologies to fuel future innovation, and understood the scientific context needed for strategic decision making. Best suited for Heads of Business Development, Search & Evaluation, and Asset Scouting for Oncology & Immunology
- Innovative Biotech: Gained feedback on pitches, data packages, and an understanding of partnership expectations with pharma and investors. Best suited for C-level executives and BD leaders across TPD, ADCS, BsABs, TCEs, and in vivo CAR-Ts
- Investors & Venture Capital: Demonstrated industry specific thought leadership whilst engaging with both earlier stage programs and validated clinical data, and understood the direction of pharma’s deal-making strategy for future exits. Best suited for leaders in corporate venture and venture capital.
Marrying collaboration across shared interests whilst delivering modality-specific depth, pharma leaders assessed related programs without dilution; and biotech executives gained more efficient, higher-yielding networking than at any other conference.
What You Missed?
Pharma Icebreaker Discussion: Insights into Big Pharma’s Wish List
Hear insights into what pharma was looking for directly from business development leads to ensure attendees shared the right information in the private meetings that followed. Did pharma want a lead candidate? What was the key element of differentiation? And what kind of data package needed to be shown to make a deal? For biotech companies looking to confidently introduce or update their programs, this was a deliberate opportunity to understand each pharma’s needs from the outset.
Pharma & Investor Icebreaker Roundtables: Unlock Connections & Break the Ice
Following each pharma and investor panel on the morning of day one and day two respectively, attendees introduced themselves to attending leaders during the Icebreaker Roundtables. They laid the groundwork for follow-up opportunities, asked questions, and heard how other biotech companies approached conversations when differentiating their pipeline.
One-on-One Partnering System: Schedule Individual Meetings with Other Attendees
Leveraging a one-to-one partnering portal, attendees searched the full attendee list, messaged and pre-scheduled meetings in their calendars ahead of the conference, and automatically booked private meeting spaces: the most efficient way to set themselves up for success.
Presentation Availability During “Showcase Your Science” Sessions in the Agenda
At the intersection of innovative research and business conversations, this forum supports the pitching of biotech pipelines and platforms to pharma and investors. As you register, secure a 15-minute presentation slot. There will be no conflicting content happening to ensure a full and engaged audience, allowing you to generate interest from a large group of potential partners and support any private conversations.
Explore the 2026 Full Event Guide
- A 1-to-5 ratio of biotech to pharma & investors guarantees you face-to-face time with top prospects
- One-to-One Partnering with the right decision-makers to drive feedback, validation & partnerships
- Pharma & investors present in >40% of meetings
- Two formal structured networking sessions, one informal drinks reception
- Refine your strategy, strengthen your pitch, nurture your relationships to stay front-of-mind after BIO & before JPM
2026 Speaker Faculty
2026 Partners
Sorry, we couldn't find any posts. Please try a different search.
Attending Companies Included
Explore Related Events
Review the 2026 Program
Determine whether this highly targeted partnering event helped accelerate your partnering objectives. Explore the event format, expert speaker faculty, and presentations delivered to see how attendees connected with the right decision-makers and maximized their time onsite.
Elevate Your Brand
Register Your Interest
Attendees connected with innovators, investors, and strategic partners at a uniquely timed event designed to bridge the gap between BIO and JPM. Take advantage of our partnering event series and register your interest in upcoming opportunities to connect with innovators, investors, and strategic partners